期刊文献+

降香挥发油固体脂质纳米粒的制备 被引量:3

Preparation of solid lipid nanoparticles containing volatile oil of Lignum dalbergia odoriferae
在线阅读 下载PDF
导出
摘要 目的 :开发降香挥发油的新型给药系统 ,提高药物利用率。方法 :用熔融 超声法制备了降香挥发油固体脂质纳米粒混悬液 ;用HPLC法测定了纳米混悬液的含药量和包封率。结果 :降香挥发油固体脂质纳米粒为类球形实体粒子 ,体积平均粒径为 4 0 .0nm ,含药量为 72 .11% ,包封率为 91.2 7%。结论 :固体脂质纳米粒作为降香挥发油的新型给药系统具有广阔的发展前景。 AIM: To delevop new drug delivery system for volatile oil of lignum dalbergia odoriferae and to improve its effect. METHODS: Solid-lipid-nanopaticals were prepared by hot-dispersiom technique and treated further by sonication; the contents of dispersion and entrapment efficiency of nanoparticles were determined by HPLC. RESULTS: Solid lipid nanoparticles containing volatile oil of lignum dalbergia odoriferae was spherelike; The partical size was 40.0nm; the content of dispersion was 72.1%; entrapment efficiency of nanoparticles was 91.27%. CONCLUSION: Solid-lipid-nanopatical may be a suitable drug delivery system for volatile oil of lignum dalbergia odoriferae.
出处 《中成药》 CAS CSCD 北大核心 2004年第6期434-437,共4页 Chinese Traditional Patent Medicine
关键词 降香挥发油 固体脂质纳米粒 熔融-超声法 包封率 volatile oil of lignum dalbergia odoriferae solid lipid nanoparticle sonication entrapment efficiency
  • 相关文献

参考文献17

  • 1刘心纯,赖小平,赖秀珍,张丹雁,黄海波.降香的鉴别及其挥发油含量和成分研究[J].广州中医学院学报,1992,9(2):102-106. 被引量:16
  • 2郭济贤 田珍 等.降香挥发油化学成分的鉴定[J].药物分析杂志,1983,3(1):4-6.
  • 3王建新,张志荣.固体脂质纳米粒的研究进展[J].中国药学杂志,2001,36(2):73-76. 被引量:62
  • 4郑虎占.中药现代化研究与应用[M].北京:学苑出版社,1998.3155.
  • 5朱亮,冷红文,谭力伟,郭济贤.降香挥发油对血栓形成、血小板cAMP和血浆纤溶酶活性的影响[J].中成药,1992,14(4):30-31. 被引量:52
  • 6肖延龄,李伯.载药纳米微粒与中药现代化[J].中草药,2002,33(5):385-388. 被引量:7
  • 7Muller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles(SLN)-an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm, 1995,41:62.
  • 8Muller RH, Maassen S, Schwarz C, et al. Solid lipid nanoparticles(SLN) as potential carrier for human use: interaction with human granulocytes. J Control Release, 1997,47:261.
  • 9Muller RH, Ruhl D, Runge S, et al. Cytotoxicity of Solid lipid nanoparticles as a function of the lipid matrix and the surfactant.Pharm Res, 1997,14:458.
  • 10Lenaerts V, Labib A, Chouinard F, et al. Nanocapsules with a reduced liver uptake: targeting of phthalocyanines to EMT-6mouse mammary tumour in vivo. Eur J Pharm Biopharm, 1995,41:38.

二级参考文献23

共引文献140

同被引文献75

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部